I was corrected for suggesting RRL's last year exploration spend of $18m was all on Mcphillamys. Fair enough.
Slide 5 note 2 of this prez forecasts FY22 Mcphillamys exploration spend of $29m.
Holders chafe at approval delays which stand between them and the immediate capitalisation of Mcphillamys full value.
RRL continues to advance the project and look confident of ultimate success.
Ash
- Forums
- ASX - By Stock
- Ann: 2022 Bell Potter Unearthed Conference Presentation
I was corrected for suggesting RRL's last year exploration spend...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RRL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.46 |
Change
-0.005(0.20%) |
Mkt cap ! $1.847B |
Open | High | Low | Value | Volume |
$2.44 | $2.46 | $2.42 | $7.462M | 3.057M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 39365 | $2.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.21 | 2178 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39365 | 2.750 |
7 | 28027 | 2.700 |
2 | 69490 | 2.630 |
6 | 6238 | 2.590 |
5 | 266081 | 2.570 |
Price($) | Vol. | No. |
---|---|---|
2.210 | 2178 | 2 |
2.260 | 119036 | 5 |
2.310 | 19 | 1 |
2.320 | 4791 | 1 |
2.330 | 50717 | 8 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online